25 XP   0   0   10

Molecular Templates Inc
Buy, Hold or Sell?

Let's analyse Molecular Templates Inc together

PenkeI guess you are interested in Molecular Templates Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Molecular Templates Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Molecular Templates Inc

I send you an email if I find something interesting about Molecular Templates Inc.

Quick analysis of Molecular Templates Inc (30 sec.)










What can you expect buying and holding a share of Molecular Templates Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
$0.78
Expected worth in 1 year
$4.38
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$3.60
Return On Investment
225.0%

For what price can you sell your share?

Current Price per Share
$1.60
Expected price per share
$0 - $3.26
How sure are you?
50%

1. Valuation of Molecular Templates Inc (5 min.)




Live pricePrice per Share (EOD)

$1.60

Intrinsic Value Per Share

$-36.88 - $144.77

Total Value Per Share

$-36.09 - $145.55

2. Growth of Molecular Templates Inc (5 min.)




Is Molecular Templates Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$4.2m$15.5m-$15.4m-14,538.6%

How much money is Molecular Templates Inc making?

Current yearPrevious yearGrowGrow %
Making money-$538.2k-$23.7m$23.1m4,309.2%
Net Profit Margin-33.5%-568.1%--

How much money comes from the company's main activities?

3. Financial Health of Molecular Templates Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#762 / 1010

Most Revenue
#269 / 1010

Most Profit
#212 / 1010

Most Efficient
#509 / 1010

What can you expect buying and holding a share of Molecular Templates Inc? (5 min.)

Welcome investor! Molecular Templates Inc's management wants to use your money to grow the business. In return you get a share of Molecular Templates Inc.

What can you expect buying and holding a share of Molecular Templates Inc?

First you should know what it really means to hold a share of Molecular Templates Inc. And how you can make/lose money.

Speculation

The Price per Share of Molecular Templates Inc is $1.6. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Molecular Templates Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Molecular Templates Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.78. Based on the TTM, the Book Value Change Per Share is $0.90 per quarter. Based on the YOY, the Book Value Change Per Share is $-3.76 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Molecular Templates Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.73-45.9%0.010.5%-1.34-83.8%-2.66-166.3%-1.59-99.5%
Usd Book Value Change Per Share-0.48-30.1%0.9056.2%-3.76-234.9%-0.90-56.2%0.138.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.3%
Usd Total Gains Per Share-0.48-30.1%0.9056.2%-3.76-234.9%-0.90-56.2%0.138.3%
Usd Price Per Share3.73-2.73-1.36-6.48-5.01-
Price to Earnings Ratio-1.27-0.19--0.80--0.55--0.72-
Price-to-Total Gains Ratio-7.74--1.44--1.18--1.83--0.96-
Price to Book Ratio4.76-2.10-4.04-1.62-0.75-
Price-to-Total Gains Ratio-7.74--1.44--1.18--1.83--0.96-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.6
Number of shares625
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.90-0.90
Usd Total Gains Per Share0.90-0.90
Gains per Quarter (625 shares)562.40-562.21
Gains per Year (625 shares)2,249.61-2,248.84
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10225022400-2249-2259
20449944900-4498-4508
30674967400-6747-6757
40899889901-8996-9006
5011248112401-11245-11255
6013498134901-13494-13504
7015747157401-15743-15753
8017997179901-17992-18002
9020246202401-20241-20251
10022496224902-22490-22500

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%2.010.00.016.7%2.018.00.010.0%4.036.00.010.0%7.070.00.09.1%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%5.015.00.025.0%12.028.00.030.0%21.056.00.027.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%1.00.019.05.0%2.00.038.05.0%2.00.075.02.6%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%5.015.00.025.0%12.028.00.030.0%21.056.00.027.3%

Fundamentals of Molecular Templates Inc

About Molecular Templates Inc

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company primarily develops therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT- 8421, an ETB candidate that is in Phase I clinical trial for the treatment of dismantling TME through direct cell-kill of tumor and immune cell; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory multiple myeloma; and MT-6402 in that is in Phase I clinical trial for relapsed/refractory patients with PD-L1 expressing tumors. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.

Fundamental data was last updated by Penke on 2024-04-11 15:17:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Molecular Templates Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Molecular Templates Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Molecular Templates Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -56.3% means that $-0.56 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Molecular Templates Inc:

  • The MRQ is -56.3%. The company is making a huge loss. -2
  • The TTM is -33.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-56.3%TTM-33.5%-22.8%
TTM-33.5%YOY-568.1%+534.7%
TTM-33.5%5Y-479.0%+445.5%
5Y-479.0%10Y-474.0%-5.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-56.3%-207.2%+150.9%
TTM-33.5%-216.8%+183.3%
YOY-568.1%-282.3%-285.8%
5Y-479.0%-436.8%-42.2%
10Y-474.0%-597.3%+123.3%
1.1.2. Return on Assets

Shows how efficient Molecular Templates Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Molecular Templates Inc to the Biotechnology industry mean.
  • -11.2% Return on Assets means that Molecular Templates Inc generated $-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Molecular Templates Inc:

  • The MRQ is -11.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.2%TTM-5.4%-5.8%
TTM-5.4%YOY-18.9%+13.5%
TTM-5.4%5Y-13.2%+7.8%
5Y-13.2%10Y-8.4%-4.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.2%-13.3%+2.1%
TTM-5.4%-12.8%+7.4%
YOY-18.9%-11.6%-7.3%
5Y-13.2%-13.8%+0.6%
10Y-8.4%-15.6%+7.2%
1.1.3. Return on Equity

Shows how efficient Molecular Templates Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Molecular Templates Inc to the Biotechnology industry mean.
  • -93.7% Return on Equity means Molecular Templates Inc generated $-0.94 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Molecular Templates Inc:

  • The MRQ is -93.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -8.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-93.7%TTM-8.2%-85.6%
TTM-8.2%YOY-185.2%+177.0%
TTM-8.2%5Y-56.7%+48.5%
5Y-56.7%10Y-28.5%-28.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-93.7%-16.9%-76.8%
TTM-8.2%-16.1%+7.9%
YOY-185.2%-14.9%-170.3%
5Y-56.7%-19.3%-37.4%
10Y-28.5%-20.1%-8.4%

1.2. Operating Efficiency of Molecular Templates Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Molecular Templates Inc is operating .

  • Measures how much profit Molecular Templates Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Molecular Templates Inc to the Biotechnology industry mean.
  • An Operating Margin of -76.6% means the company generated $-0.77  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Molecular Templates Inc:

  • The MRQ is -76.6%. The company is operating very inefficient. -2
  • The TTM is -39.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-76.6%TTM-39.9%-36.6%
TTM-39.9%YOY-536.9%+496.9%
TTM-39.9%5Y-434.9%+394.9%
5Y-434.9%10Y-431.5%-3.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-76.6%-298.0%+221.4%
TTM-39.9%-238.5%+198.6%
YOY-536.9%-288.4%-248.5%
5Y-434.9%-486.2%+51.3%
10Y-431.5%-628.4%+196.9%
1.2.2. Operating Ratio

Measures how efficient Molecular Templates Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.77 means that the operating costs are $1.77 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Molecular Templates Inc:

  • The MRQ is 1.766. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.438. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.766TTM2.438-0.673
TTM2.438YOY6.795-4.357
TTM2.4385Y6.199-3.760
5Y6.19910Y7.421-1.222
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7663.235-1.469
TTM2.4383.310-0.872
YOY6.7953.838+2.957
5Y6.1995.679+0.520
10Y7.4217.823-0.402

1.3. Liquidity of Molecular Templates Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Molecular Templates Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.97 means the company has $0.97 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Molecular Templates Inc:

  • The MRQ is 0.968. The company is just not able to pay all its short-term debts. -1
  • The TTM is 1.047. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ0.968TTM1.047-0.079
TTM1.047YOY2.064-1.017
TTM1.0475Y2.548-1.500
5Y2.54810Y3.722-1.175
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9683.863-2.895
TTM1.0474.169-3.122
YOY2.0645.337-3.273
5Y2.5486.122-3.574
10Y3.7226.434-2.712
1.3.2. Quick Ratio

Measures if Molecular Templates Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Molecular Templates Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.68 means the company can pay off $0.68 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Molecular Templates Inc:

  • The MRQ is 0.680. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.798. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.680TTM0.798-0.119
TTM0.798YOY3.324-2.525
TTM0.7985Y3.827-3.028
5Y3.82710Y5.248-1.421
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6803.504-2.824
TTM0.7983.991-3.193
YOY3.3245.371-2.047
5Y3.8276.088-2.261
10Y5.2486.395-1.147

1.4. Solvency of Molecular Templates Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Molecular Templates Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Molecular Templates Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.88 means that Molecular Templates Inc assets are financed with 88.1% credit (debt) and the remaining percentage (100% - 88.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Molecular Templates Inc:

  • The MRQ is 0.881. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.999. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.881TTM0.999-0.118
TTM0.999YOY0.912+0.087
TTM0.9995Y0.689+0.310
5Y0.68910Y0.647+0.042
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8810.339+0.542
TTM0.9990.337+0.662
YOY0.9120.271+0.641
5Y0.6890.368+0.321
10Y0.6470.388+0.259
1.4.2. Debt to Equity Ratio

Measures if Molecular Templates Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Molecular Templates Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 740.1% means that company has $7.40 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Molecular Templates Inc:

  • The MRQ is 7.401. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.220. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ7.401TTM3.220+4.181
TTM3.220YOY8.622-5.402
TTM3.2205Y3.068+0.151
5Y3.06810Y1.623+1.446
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.4010.392+7.009
TTM3.2200.403+2.817
YOY8.6220.335+8.287
5Y3.0680.427+2.641
10Y1.6230.461+1.162

2. Market Valuation of Molecular Templates Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Molecular Templates Inc generates.

  • Above 15 is considered overpriced but always compare Molecular Templates Inc to the Biotechnology industry mean.
  • A PE ratio of -1.27 means the investor is paying $-1.27 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Molecular Templates Inc:

  • The EOD is -0.545. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.269. Based on the earnings, the company is expensive. -2
  • The TTM is 0.191. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-0.545MRQ-1.269+0.725
MRQ-1.269TTM0.191-1.460
TTM0.191YOY-0.804+0.994
TTM0.1915Y-0.548+0.738
5Y-0.54810Y-0.721+0.173
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.545-2.300+1.755
MRQ-1.269-2.656+1.387
TTM0.191-2.718+2.909
YOY-0.804-4.145+3.341
5Y-0.548-6.258+5.710
10Y-0.721-6.315+5.594
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Molecular Templates Inc:

  • The EOD is -0.407. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.948. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.542. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.407MRQ-0.948+0.541
MRQ-0.948TTM-0.542-0.406
TTM-0.542YOY-0.702+0.160
TTM-0.5425Y-0.431-0.111
5Y-0.43110Y-0.444+0.013
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.407-2.974+2.567
MRQ-0.948-3.306+2.358
TTM-0.542-3.508+2.966
YOY-0.702-5.613+4.911
5Y-0.431-8.378+7.947
10Y-0.444-8.873+8.429
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Molecular Templates Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 4.76 means the investor is paying $4.76 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Molecular Templates Inc:

  • The EOD is 2.042. Based on the equity, the company is underpriced. +1
  • The MRQ is 4.759. Based on the equity, the company is fair priced.
  • The TTM is 2.097. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.042MRQ4.759-2.718
MRQ4.759TTM2.097+2.662
TTM2.097YOY4.037-1.940
TTM2.0975Y1.618+0.479
5Y1.61810Y0.750+0.868
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.0421.914+0.128
MRQ4.7592.116+2.643
TTM2.0972.0970.000
YOY4.0372.881+1.156
5Y1.6183.550-1.932
10Y0.7503.936-3.186
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Molecular Templates Inc.

3.1. Institutions holding Molecular Templates Inc

Institutions are holding 63.85% of the shares of Molecular Templates Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Bellevue Group AG19.16210.05881029820-1793-0.1738
2023-09-30Bvf Inc9.89970.09075320385320380
2023-12-31SILVERARC CAPITAL MANAGEMENT, LLC6.59830.393735460800
2023-12-31Adage Capital Partners Gp LLC5.44750.002329276400
2023-12-31Caxton Corp2.54672.755913686600
2023-12-31Vanguard Group Inc2.337501256231496713.5257
2023-12-31Monashee Investment Management LLC2.26710.0802121841-20000-14.1003
2023-12-31BlackRock Inc0.737703964500
2023-12-31Geode Capital Management, LLC0.68303670500
2023-12-31Renaissance Technologies Corp0.44010.000123653789550.1015
2023-12-31The Carlyle Group Inc0.24810.00241333300
2023-12-31Virtu Financial LLC0.19380.003110416104160
2023-12-31Morgan Stanley - Brokerage Accounts0.09720522600
2023-12-31PFS Partners, LLC0.0620.0085333300
2023-12-31Tower Research Capital LLC0.03350.000117991125166.9139
2023-12-31Acadian Asset Management LLC0.024201300-9637-88.1137
2023-12-31Barclays PLC0.00703753750
2023-12-31Advisor Group Holdings, Inc.0.00510275-275-50
2023-12-31Bank of America Corp0.00430230-42-15.4412
2023-12-31Royal Bank of Canada0.00380202-206-50.4902
Total 50.79873.39582730052+534863+19.6%

3.2. Funds holding Molecular Templates Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30BB Biotech AG Ord19.16210.2682102982028376138.0347
2024-02-29Vanguard Total Stock Mkt Idx Inv1.350507257800
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.92830.00024988800
2023-06-30Bellevue (Lux) Bellevue Glbl Mac I EUR0.04710.01643800000
2024-02-29Fidelity Extended Market Index0.44580.000223960-116-0.4818
2023-09-30BlackRock Extended Mkt Composite0.14070.0003756200
2024-03-31BlackRock Extended Equity Market K0.12280.0001660020.0303
2023-12-31NT Ext Equity Mkt Idx Fd - L0.09420.0003506400
2023-12-31Northern Trust Extended Eq Market Idx0.09420.0003506400
2024-02-29Fidelity Total Market Index0.07380396400
2024-02-29Fidelity Series Total Market Index0.07220388000
2024-02-29Fidelity Nasdaq Composite Index0.06470.0001347700
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.04580.0001246200
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.03680.0002197740.2027
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.035501906-66817-97.2265
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.03550190600
2024-02-29Spartan Total Market Index Pool E0.02360126700
2024-02-29Vanguard Balanced Index Inv0.02310124100
2024-03-31BlackRock U.S. Equity Market F0.022801226120.9885
2024-03-31State St US Extended Mkt Indx NL Cl C0.02270.0001121900
Total 22.84220.28651263061+216846+17.2%

3.3. Insider Transactions

Insiders are holding 5.165% of the shares of Molecular Templates Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-02Target N V BiotechBUY2500002.35
2023-07-17Target N V BiotechBUY2836877.05

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Molecular Templates Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.4820.900-154%-3.758+680%-0.900+87%0.128-475%
Book Value Per Share--0.7840.020+3864%-0.361+146%8.941-91%6.813-88%
Current Ratio--0.9681.047-8%2.064-53%2.548-62%3.722-74%
Debt To Asset Ratio--0.8810.999-12%0.912-3%0.689+28%0.647+36%
Debt To Equity Ratio--7.4013.220+130%8.622-14%3.068+141%1.623+356%
Dividend Per Share----0%-0%0.000-100%0.004-100%
Eps---0.7350.008-8777%-1.341+83%-2.661+262%-1.592+117%
Free Cash Flow Per Share---0.984-1.955+99%-1.198+22%-2.123+116%-1.601+63%
Free Cash Flow To Equity Per Share---0.984-3.658+272%-1.213+23%-0.447-55%0.047-2196%
Gross Profit Margin--1.3251.081+23%1.000+32%1.016+30%1.008+31%
Intrinsic Value_10Y_max--144.765--------
Intrinsic Value_10Y_min---36.878--------
Intrinsic Value_1Y_max---3.324--------
Intrinsic Value_1Y_min---5.981--------
Intrinsic Value_3Y_max--3.602--------
Intrinsic Value_3Y_min---16.097--------
Intrinsic Value_5Y_max--26.911--------
Intrinsic Value_5Y_min---24.083--------
Market Cap8598832.000-133%20046027.10014658187.068+37%72402866.885-72%47829235.423-58%33452173.452-40%
Net Profit Margin---0.563-0.335-41%-5.681+910%-4.790+751%-4.740+742%
Operating Margin---0.766-0.399-48%-5.369+601%-4.349+468%-4.315+464%
Operating Ratio--1.7662.438-28%6.795-74%6.199-72%7.421-76%
Pb Ratio2.042-133%4.7592.097+127%4.037+18%1.618+194%0.750+535%
Pe Ratio-0.545+57%-1.2690.191-765%-0.804-37%-0.548-57%-0.721-43%
Price Per Share1.600-133%3.7302.727+37%1.360+174%6.477-42%5.013-26%
Price To Free Cash Flow Ratio-0.407+57%-0.948-0.542-43%-0.702-26%-0.431-55%-0.444-53%
Price To Total Gains Ratio-3.321+57%-7.743-1.444-81%-1.183-85%-1.826-76%-0.956-88%
Quick Ratio--0.6800.798-15%3.324-80%3.827-82%5.248-87%
Return On Assets---0.112-0.054-52%-0.189+69%-0.132+18%-0.084-25%
Return On Equity---0.937-0.082-91%-1.852+98%-0.567-40%-0.285-70%
Total Gains Per Share---0.4820.900-154%-3.758+680%-0.900+87%0.133-462%
Usd Book Value--4212000.000106250.000+3864%15553500.000-73%51550500.000-92%38366525.000-89%
Usd Book Value Change Per Share---0.4820.900-154%-3.758+680%-0.900+87%0.128-475%
Usd Book Value Per Share--0.7840.020+3864%-0.361+146%8.941-91%6.813-88%
Usd Dividend Per Share----0%-0%0.000-100%0.004-100%
Usd Eps---0.7350.008-8777%-1.341+83%-2.661+262%-1.592+117%
Usd Free Cash Flow---5287000.000-10505000.000+99%-23055500.000+336%-14735350.000+179%-10263775.000+94%
Usd Free Cash Flow Per Share---0.984-1.955+99%-1.198+22%-2.123+116%-1.601+63%
Usd Free Cash Flow To Equity Per Share---0.984-3.658+272%-1.213+23%-0.447-55%0.047-2196%
Usd Market Cap8598832.000-133%20046027.10014658187.068+37%72402866.885-72%47829235.423-58%33452173.452-40%
Usd Price Per Share1.600-133%3.7302.727+37%1.360+174%6.477-42%5.013-26%
Usd Profit---3948000.000-538250.000-86%-23732250.000+501%-17721450.000+349%-10209575.000+159%
Usd Revenue--7016000.00013516500.000-48%4938500.000+42%7382550.000-5%8016950.000-12%
Usd Total Gains Per Share---0.4820.900-154%-3.758+680%-0.900+87%0.133-462%
 EOD+3 -5MRQTTM+16 -18YOY+26 -85Y+18 -1810Y+13 -23

4.2. Fundamental Score

Let's check the fundamental score of Molecular Templates Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.545
Price to Book Ratio (EOD)Between0-12.042
Net Profit Margin (MRQ)Greater than0-0.563
Operating Margin (MRQ)Greater than0-0.766
Quick Ratio (MRQ)Greater than10.680
Current Ratio (MRQ)Greater than10.968
Debt to Asset Ratio (MRQ)Less than10.881
Debt to Equity Ratio (MRQ)Less than17.401
Return on Equity (MRQ)Greater than0.15-0.937
Return on Assets (MRQ)Greater than0.05-0.112
Total1/10 (10.0%)

4.3. Technical Score

Let's check the technical score of Molecular Templates Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.079
Ma 20Greater thanMa 501.777
Ma 50Greater thanMa 1002.613
Ma 100Greater thanMa 2003.220
OpenGreater thanClose1.640
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets35,383
Total Liabilities31,171
Total Stockholder Equity4,212
 As reported
Total Liabilities 31,171
Total Stockholder Equity+ 4,212
Total Assets = 35,383

Assets

Total Assets35,383
Total Current Assets16,772
Long-term Assets18,611
Total Current Assets
Cash And Cash Equivalents 11,523
Net Receivables 250
Other Current Assets 4,999
Total Current Assets  (as reported)16,772
Total Current Assets  (calculated)16,772
+/-0
Long-term Assets
Property Plant Equipment 16,554
Long-term Assets Other 742
Long-term Assets  (as reported)18,611
Long-term Assets  (calculated)17,296
+/- 1,315

Liabilities & Shareholders' Equity

Total Current Liabilities17,321
Long-term Liabilities13,850
Total Stockholder Equity4,212
Total Current Liabilities
Short-term Debt 2,488
Accounts payable 1,523
Other Current Liabilities 4,279
Total Current Liabilities  (as reported)17,321
Total Current Liabilities  (calculated)8,290
+/- 9,031
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt9,742
Long-term Liabilities Other 4,108
Long-term Liabilities  (as reported)13,850
Long-term Liabilities  (calculated)13,850
+/- 0
Total Stockholder Equity
Common Stock5
Retained Earnings -452,892
Other Stockholders Equity 457,099
Total Stockholder Equity (as reported)4,212
Total Stockholder Equity (calculated)4,212
+/-0
Other
Capital Stock5
Cash and Short Term Investments 11,523
Common Stock Shares Outstanding 5,374
Current Deferred Revenue9,031
Liabilities and Stockholders Equity 35,383
Net Debt 707
Net Invested Capital 4,212
Net Working Capital -549
Property Plant and Equipment Gross 43,602
Short Long Term Debt Total 12,230



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-30
> Total Assets 
31,375
32,213
64,068
57,951
49,496
102,101
91,437
81,202
68,137
57,034
46,644
38,916
33,005
25,814
20,891
16,645
28,982
24,531
19,118
14,474
20,880
48,685
43,416
28,183
21,922
16,204
39,798
32,992
26,875
22,436
89,714
86,342
86,218
89,521
113,872
104,505
101,045
104,118
94,680
84,172
76,670
68,396
88,009
73,854
63,964
53,669
41,050
36,180
29,691
24,283
19,953
20,861
102,537
90,391
87,215
79,416
151,960
140,158
140,605
131,147
93,162
174,202
160,743
142,410
169,377
139,877
251,774
244,761
217,929
192,362
163,165
140,804
118,646
97,548
78,505
35,512
44,061
35,383
35,38344,06135,51278,50597,548118,646140,804163,165192,362217,929244,761251,774139,877169,377142,410160,743174,20293,162131,147140,605140,158151,96079,41687,21590,391102,53720,86119,95324,28329,69136,18041,05053,66963,96473,85488,00968,39676,67084,17294,680104,118101,045104,505113,87289,52186,21886,34289,71422,43626,87532,99239,79816,20421,92228,18343,41648,68520,88014,47419,11824,53128,98216,64520,89125,81433,00538,91646,64457,03468,13781,20291,437102,10149,49657,95164,06832,21331,375
   > Total Current Assets 
30,878
30,354
62,033
55,855
47,506
100,217
88,539
77,206
64,229
53,357
43,210
35,763
30,134
23,209
18,515
14,511
27,076
22,855
17,657
13,169
19,624
47,657
42,432
27,009
20,817
15,643
39,309
32,574
26,117
20,544
88,038
84,599
84,431
87,650
112,053
102,673
99,278
86,009
78,496
70,142
74,096
66,680
82,104
72,166
62,231
53,170
40,623
35,806
29,532
24,174
19,953
20,861
69,582
60,414
54,896
44,154
116,827
104,863
90,960
79,840
64,146
139,899
124,198
108,080
129,655
101,324
209,181
205,279
177,444
148,215
132,385
111,091
87,185
68,298
51,624
11,823
22,700
16,772
16,77222,70011,82351,62468,29887,185111,091132,385148,215177,444205,279209,181101,324129,655108,080124,198139,89964,14679,84090,960104,863116,82744,15454,89660,41469,58220,86119,95324,17429,53235,80640,62353,17062,23172,16682,10466,68074,09670,14278,49686,00999,278102,673112,05387,65084,43184,59988,03820,54426,11732,57439,30915,64320,81727,00942,43247,65719,62413,16917,65722,85527,07614,51118,51523,20930,13435,76343,21053,35764,22977,20688,539100,21747,50655,85562,03330,35430,878
       Cash And Cash Equivalents 
16,237
14,339
44,983
39,913
33,275
74,947
53,888
46,060
38,402
28,450
21,404
16,437
15,909
11,404
12,927
11,002
22,947
15,466
12,342
5,278
4,205
8,934
6,698
3,729
3,939
8,691
29,919
10,597
6,076
5,882
25,935
8,307
8,634
11,029
20,355
4,413
4,001
7,279
6,743
6,463
11,240
8,391
21,063
10,569
13,709
9,589
11,211
12,402
15,155
10,551
11,438
16,468
68,181
58,910
49,275
41,647
78,744
87,721
37,855
16,795
15,268
85,451
34,444
27,645
33,410
25,218
98,786
43,090
27,593
24,983
19,572
26,936
22,277
32,190
38,782
4,952
15,811
11,523
11,52315,8114,95238,78232,19022,27726,93619,57224,98327,59343,09098,78625,21833,41027,64534,44485,45115,26816,79537,85587,72178,74441,64749,27558,91068,18116,46811,43810,55115,15512,40211,2119,58913,70910,56921,0638,39111,2406,4636,7437,2794,0014,41320,35511,0298,6348,30725,9355,8826,07610,59729,9198,6913,9393,7296,6988,9344,2055,27812,34215,46622,94711,00212,92711,40415,90916,43721,40428,45038,40246,06053,88874,94733,27539,91344,98314,33916,237
       Short-term Investments 
12,982
14,326
16,084
14,618
12,814
24,707
33,559
30,101
25,061
24,360
20,810
18,430
13,554
11,289
4,969
2,707
3,602
6,871
4,919
7,505
4,284
28,381
25,206
22,398
16,113
6,008
8,447
20,897
19,211
14,408
23,796
58,228
57,191
59,819
83,883
93,799
87,913
58,390
65,250
56,571
56,505
50,209
57,822
56,450
42,705
39,091
26,755
21,189
12,955
13,000
6,163
300
0
0
0
0
0
10,234
45,720
55,529
36,147
39,633
70,544
63,361
82,816
68,667
103,498
154,512
141,783
118,061
104,947
77,489
57,168
28,859
2,889
0
0
0
0002,88928,85957,16877,489104,947118,061141,783154,512103,49868,66782,81663,36170,54439,63336,14755,52945,72010,234000003006,16313,00012,95521,18926,75539,09142,70556,45057,82250,20956,50556,57165,25058,39087,91393,79983,88359,81957,19158,22823,79614,40819,21120,8978,4476,00816,11322,39825,20628,3814,2847,5054,9196,8713,6022,7074,96911,28913,55418,43020,81024,36025,06130,10133,55924,70712,81414,61816,08414,32612,982
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
37,540
16,412
17,457
15,635
6,653
2,548
5,545
18,094
5,192
4,263
4,463
7,248
1,993
3,647
4,032
1,891
777
921
400
0
2,000
4,000
38
0
4,000
663
31,163
240
295
5,160
5,591
7,508
10,741
9,067
3,791
234
234
0
0
0
0
0
0
0
2,838
274
0
250
25002742,83800000002342343,7919,06710,7417,5085,5915,16029524031,1636634,0000384,0002,00004009217771,8914,0323,6471,9937,2484,4634,2635,19218,0945,5452,5486,65315,63517,45716,41237,540000000000000000000000000000000
       Other Current Assets 
85
1,689
966
1,324
1,417
563
1,092
1,045
766
547
996
896
671
516
619
802
527
518
396
386
11,135
10,342
10,528
882
765
944
943
1,080
830
254
37,540
1,652
1,149
1,167
1,162
1,913
1,819
2,246
1,311
2,845
1,888
832
1,226
1,500
1,785
2,599
1,880
1,294
1,022
623
352
93
1,363
19
144
191
4,385
4,424
5,085
98
300
489
242
160
249
1,125
719
465
445
1,254
5,251
4,271
4,011
3,790
5,106
2,710
3,890
4,999
4,9993,8902,7105,1063,7904,0114,2715,2511,2544454657191,125249160242489300985,0854,4244,385191144191,363933526231,0221,2941,8802,5991,7851,5001,2268321,8882,8451,3112,2461,8191,9131,1621,1671,1491,65237,5402548301,08094394476588210,52810,34211,1353863965185278026195166718969965477661,0451,0925631,4171,3249661,68985
   > Long-term Assets 
497
1,859
2,035
2,096
1,990
1,884
2,898
3,996
3,908
3,677
3,434
3,153
2,871
2,605
2,376
2,134
1,906
1,676
1,461
1,305
1,256
1,028
984
1,174
1,105
561
489
418
758
1,892
1,676
1,743
1,787
1,871
1,819
1,832
1,767
18,109
16,184
14,030
2,574
1,716
5,905
1,688
1,733
499
427
374
159
109
109
0
32,955
29,977
32,319
35,262
35,133
35,295
49,645
51,307
29,016
34,303
36,545
34,330
39,722
38,553
42,593
39,482
40,485
44,147
30,780
29,713
31,461
29,250
26,881
23,689
21,361
18,611
18,61121,36123,68926,88129,25031,46129,71330,78044,14740,48539,48242,59338,55339,72234,33036,54534,30329,01651,30749,64535,29535,13335,26232,31929,97732,95501091091593744274991,7331,6885,9051,7162,57414,03016,18418,1091,7671,8321,8191,8711,7871,7431,6761,8927584184895611,1051,1749841,0281,2561,3051,4611,6761,9062,1342,3762,6052,8713,1533,4343,6773,9083,9962,8981,8841,9902,0962,0351,859497
       Property Plant Equipment 
305
1,667
1,818
1,878
1,773
1,667
2,389
3,487
3,399
3,169
2,926
2,645
2,363
2,097
1,868
1,626
1,398
1,168
953
782
647
505
473
413
344
271
199
128
409
543
617
684
728
812
760
773
708
686
632
690
637
557
503
424
404
333
261
208
159
109
109
0
963
1,952
4,294
7,237
7,165
6,851
18,239
19,947
24,281
28,117
28,918
29,490
32,478
33,358
32,332
31,344
29,453
27,917
26,840
25,707
27,467
25,764
23,466
20,321
18,245
16,554
16,55418,24520,32123,46625,76427,46725,70726,84027,91729,45331,34432,33233,35832,47829,49028,91828,11724,28119,94718,2396,8517,1657,2374,2941,95296301091091592082613334044245035576376906326867087737608127286846175434091281992713444134735056477829531,1681,3981,6261,8682,0972,3632,6452,9263,1693,3993,4872,3891,6671,7731,8781,8181,667305
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,314
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000003,3140000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,364
14,393
12,181
778
0
4,201
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,510
3,010
0
2,000
0
5,115
3,072
6,013
8,986
0
0
0
0
0
0
0
0
000000008,9866,0133,0725,11502,00003,0101,5100000000000000000004,201077812,18114,39316,3640000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
333
0
0
0
0
0
0
28,621
28,025
26,623
26,623
26,623
26,623
26,623
26,623
0
1,200
0
0
0
0
0
0
0
0
0
0
0
700
0
0
0
0
0000700000000000001,200026,62326,62326,62326,62326,62326,62328,02528,621000000333000000000000000000000000000000000000000000000
       Long-term Assets Other 
192
192
217
218
217
217
509
509
509
508
508
508
508
508
508
508
508
508
508
523
609
523
511
761
761
290
290
290
349
1,349
1,059
1,059
1,059
1,059
1,059
1,059
1,059
1,059
1,159
1,159
1,159
1,159
1,201
1,264
1,329
166
166
166
0
0
0
0
57
1,402
1,402
1,402
1,345
1,821
4,783
4,737
4,735
4,676
4,617
4,840
5,244
5,195
5,146
5,066
5,019
7,244
3,940
1,306
1,505
3,486
926
1,053
801
742
7428011,0539263,4861,5051,3063,9407,2445,0195,0665,1465,1955,2444,8404,6174,6764,7354,7374,7831,8211,3451,4021,4021,4025700001661661661,3291,2641,2011,1591,1591,1591,1591,0591,0591,0591,0591,0591,0591,0591,0591,349349290290290761761511523609523508508508508508508508508508508509509509217217218217192192
> Total Liabilities 
52,315
58,686
8,685
11,168
11,176
12,733
12,627
15,129
16,039
12,795
10,007
8,332
7,441
6,227
5,161
4,087
3,498
3,117
4,162
5,244
17,311
26,028
26,586
11,388
10,715
11,261
19,316
20,255
17,421
17,953
167,161
137,716
130,302
103,374
135,687
129,715
118,545
127,593
123,668
112,425
97,673
92,372
107,898
100,157
94,859
12,823
7,178
8,366
6,770
4,395
4,626
3,974
14,638
13,102
16,274
17,240
45,768
39,252
44,468
41,887
40,146
71,174
76,977
86,551
84,936
80,537
143,419
147,359
145,824
126,700
115,683
115,092
114,494
112,680
80,415
44,190
37,260
31,171
31,17137,26044,19080,415112,680114,494115,092115,683126,700145,824147,359143,41980,53784,93686,55176,97771,17440,14641,88744,46839,25245,76817,24016,27413,10214,6383,9744,6264,3956,7708,3667,17812,82394,859100,157107,89892,37297,673112,425123,668127,593118,545129,715135,687103,374130,302137,716167,16117,95317,42120,25519,31611,26110,71511,38826,58626,02817,3115,2444,1623,1173,4984,0875,1616,2277,4418,33210,00712,79516,03915,12912,62712,73311,17611,1688,68558,68652,315
   > Total Current Liabilities 
2,291
8,387
8,298
10,817
7,619
9,562
9,846
10,898
12,264
9,658
7,421
6,305
5,974
5,325
4,488
3,520
2,938
2,563
1,695
2,103
13,230
12,874
13,241
3,792
3,336
3,514
4,632
4,470
5,387
8,591
15,214
13,421
16,189
17,451
23,790
22,666
24,877
27,016
28,182
27,297
24,975
25,974
28,975
25,528
24,258
10,828
5,575
5,789
3,719
2,616
2,210
2,480
11,307
10,442
12,107
13,276
41,731
32,509
28,100
25,693
24,098
35,801
43,836
41,401
40,397
37,553
76,576
44,708
47,397
46,670
45,024
46,613
50,222
57,082
29,900
26,937
21,512
17,321
17,32121,51226,93729,90057,08250,22246,61345,02446,67047,39744,70876,57637,55340,39741,40143,83635,80124,09825,69328,10032,50941,73113,27612,10710,44211,3072,4802,2102,6163,7195,7895,57510,82824,25825,52828,97525,97424,97527,29728,18227,01624,87722,66623,79017,45116,18913,42115,2148,5915,3874,4704,6323,5143,3363,79213,24112,87413,2302,1031,6952,5632,9383,5204,4885,3255,9746,3057,4219,65812,26410,8989,8469,5627,61910,8178,2988,3872,291
       Short-term Debt 
211
331
334
314
272
230
188
984
991
997
970
943
926
909
926
800
571
337
99
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
667
0
0
0
2,400
16,735
18,757
2,399
2,400
2,800
6,231
6,595
5,357
5,979
7,120
9,105
14,544
11,531
14,129
13,231
2,211
9,801
2,464
2,541
2,606
0
2,459
1,957
2,182
2,286
2,349
2,416
2,488
2,4882,4162,3492,2862,1821,9572,45902,6062,5412,4649,8012,21113,23114,12911,53114,5449,1057,1205,9795,3576,5956,2312,8002,4002,39918,75716,7352,4000006670000000000000000000000000099337571800926909926943970997991984188230272314334331211
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
667
0
0
0
2,400
16,735
18,757
2,348
2,400
2,999
3,063
0
0
965
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000965003,0632,9992,4002,34818,75716,7352,400000667000000000000000000000000000000000000000000000
       Accounts payable 
835
1,550
1,041
1,112
932
1,237
1,560
778
746
619
501
719
780
1,022
615
603
355
840
228
474
517
284
611
475
471
252
604
478
305
2,389
1,307
995
739
908
2,354
884
1,375
1,689
4,006
2,891
3,414
2,074
1,809
635
436
725
1,563
3,076
699
951
328
319
3,823
2,517
2,859
1,283
1,630
780
1,582
2,577
1,414
1,465
1,770
1,660
2,565
2,350
1,804
1,907
1,311
1,612
0
1,641
1,085
504
2,718
4,669
2,583
1,523
1,5232,5834,6692,7185041,0851,64101,6121,3111,9071,8042,3502,5651,6601,7701,4651,4142,5771,5827801,6301,2832,8592,5173,8233193289516993,0761,5637254366351,8092,0743,4142,8914,0061,6891,3758842,3549087399951,3072,3893054786042524714756112845174742288403556036151,0227807195016197467781,5601,2379321,1121,0411,550835
       Other Current Liabilities 
140
5,000
5,000
5,000
4,978
6,658
6,661
7,699
9,090
6,605
4,513
3,206
2,831
1,957
1,870
1,399
1,653
1,386
1,368
1,629
12,713
12,590
12,630
3,317
2,865
3,262
4,028
3,992
5,082
6,202
6,719
5,238
8,262
8,007
8,714
9,060
10,780
10,605
9,454
9,684
6,839
9,178
12,444
10,171
9,100
10,103
4,012
2,713
3,020
1,665
1,882
2,161
1,500
2,760
98
104
106
141
1,232
1,435
1,623
2,501
10,297
7,110
7,539
18,189
14,446
9,546
11,305
9,515
10,438
9,529
8,890
8,823
5,542
3,510
3,303
4,279
4,2793,3033,5105,5428,8238,8909,52910,4389,51511,3059,54614,44618,1897,5397,11010,2972,5011,6231,4351,232141106104982,7601,5002,1611,8821,6653,0202,7134,01210,1039,10010,17112,4449,1786,8399,6849,45410,60510,7809,0608,7148,0078,2625,2386,7196,2025,0823,9924,0283,2622,8653,31712,63012,59012,7131,6291,3681,3861,6531,3991,8701,9572,8313,2064,5136,6059,0907,6996,6616,6584,9785,0005,0005,000140
   > Long-term Liabilities 
50,024
50,299
387
351
3,557
3,171
2,781
4,231
3,775
3,137
2,586
2,027
1,467
902
673
567
560
554
2,467
3,141
4,081
13,154
13,345
7,596
7,379
7,747
14,684
15,785
12,034
9,362
151,947
124,295
114,113
85,923
111,897
107,049
93,668
100,577
95,486
85,128
72,698
66,398
78,923
74,629
70,601
1,995
1,603
2,577
3,051
1,779
2,416
1,494
3,331
2,660
4,167
3,964
4,037
6,743
16,368
16,194
16,048
35,373
33,141
45,150
44,539
42,984
66,843
102,651
98,427
80,030
70,659
68,479
64,272
55,598
50,515
17,253
15,748
13,850
13,85015,74817,25350,51555,59864,27268,47970,65980,03098,427102,65166,84342,98444,53945,15033,14135,37316,04816,19416,3686,7434,0373,9644,1672,6603,3311,4942,4161,7793,0512,5771,6031,99570,60174,62978,92366,39872,69885,12895,486100,57793,668107,049111,89785,923114,113124,295151,9479,36212,03415,78514,6847,7477,3797,59613,34513,1544,0813,1412,4675545605676739021,4672,0272,5863,1373,7754,2312,7813,1713,55735138750,29950,024
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,794
1,078
2,999
3,063
3,155
3,254
3,159
3,075
3,001
2,940
2,888
14,721
14,822
14,926
15,031
35,018
35,251
35,491
0
0
0
0
0
0
0
0
0000000035,49135,25135,01815,03114,92614,82214,7212,8882,9403,0013,0753,1593,2543,1553,0632,9991,0781,7940000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,961
0
0
0
1,864
0
0
2,988
53
2,407
40
1,537
1,533
1,168
901
882
3,489
2,427
2,406
2,471
20,750
19,021
19,658
16,889
15,845
40,226
56,686
52,892
34,975
25,913
24,360
15,910
7,199
2,478
6,224
0
0
006,2242,4787,19915,91024,36025,91334,97552,89256,68640,22615,84516,88919,65819,02120,7502,4712,4062,4273,4898829011,1681,5331,537402,407532,988001,8640003,96100000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
96
4
153
50,322
48,536
46,740
53,365
76,251
73,066
69,878
77,156
73,522
69,829
66,134
66,398
78,923
74,629
70,601
1,995
1,603
2,577
3,051
1,779
2,416
1,494
1,537
954
340
42
38
2,673
2,065
1,664
0
19,385
14,523
9,728
7,785
4,538
36,117
52,544
51,302
33,350
0
0
0
0
0
19
0
0
00190000033,35051,30252,54436,1174,5387,7859,72814,52319,38501,6642,0652,67338423409541,5371,4942,4161,7793,0512,5771,6031,99570,60174,62978,92366,39866,13469,82973,52277,15669,87873,06676,25153,36546,74048,53650,322153496000000000000000000000000000
> Total Stockholder Equity
-20,940
-26,473
55,383
46,783
38,320
89,368
78,810
66,073
52,098
44,239
36,637
30,584
25,564
19,587
15,730
12,558
25,484
21,414
14,956
9,230
3,569
22,657
16,830
16,795
11,207
4,943
20,482
12,737
9,454
4,483
-77,447
-51,374
-44,084
-13,853
-21,815
-25,210
-17,500
-23,475
-28,988
-28,253
-21,003
-23,976
-19,889
-26,303
-30,895
40,846
33,872
27,814
22,921
19,888
15,327
16,887
87,899
77,289
70,941
62,176
106,192
100,906
96,137
89,260
53,016
103,028
83,766
55,859
84,441
59,340
108,355
97,402
72,105
65,662
47,482
25,712
4,152
-15,132
-1,910
-8,678
6,801
4,212
4,2126,801-8,678-1,910-15,1324,15225,71247,48265,66272,10597,402108,35559,34084,44155,85983,766103,02853,01689,26096,137100,906106,19262,17670,94177,28987,89916,88715,32719,88822,92127,81433,87240,846-30,895-26,303-19,889-23,976-21,003-28,253-28,988-23,475-17,500-25,210-21,815-13,853-44,084-51,374-77,4474,4839,45412,73720,4824,94311,20716,79516,83022,6573,5699,23014,95621,41425,48412,55815,73019,58725,56430,58436,63744,23952,09866,07378,81089,36838,32046,78355,383-26,473-20,940
   Common Stock
3
4
31
31
31
37
37
37
37
37
37
37
37
37
37
37
15
15
15
15
15
33
34
34
34
34
49
49
49
49
54
55
56
56
56
58
59
59
59
59
62
63
71
71
71
71
72
72
72
72
72
72
27
27
27
27
36
37
37
37
37
46
46
46
50
50
56
56
56
56
56
56
56
56
56
56
5
5
55565656565656565656565050464646373737373627272727727272727272717171716362595959595856565655544949494934343434331515151515373737373737373737373731313143
   Retained Earnings -452,892-448,944-444,791-433,923-444,768-422,719-398,406-373,661-352,050-341,807-311,420-295,819-269,041-240,596-217,371-186,143-164,125-148,244-110,025-100,872-94,704-88,070-82,826-73,130-64,471-57,556-357,463-358,608-353,534-349,852-344,156-337,292-329,440-399,153-392,722-384,416-373,262-367,298-359,553-358,787-351,678-344,089-345,265-332,477-323,263-351,651-350,660-367,661-252,128-246,853-242,728-234,805-226,475-219,921-214,013-213,752-207,793-203,060-196,907-190,688-183,613-178,819-174,261-170,296-165,321-157,913-151,354-143,716-134,657-125,037-108,324-92,797-78,971-63,815-52,289-42,103-34,563-26,700
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
255,418
256,267
256,563
290,159
299,244
307,497
309,343
310,600
320,024
326,492
328,116
329,727
331,224
346,229
349,236
364,471
366,366
368,190
370,236
371,091
371,893
372,699
373,352
373,864
374,278
145,428
141,733
144,044
144,975
194,226
195,573
196,972
199,223
201,203
267,089
269,581
273,012
324,914
328,314
404,116
408,758
413,857
417,704
0
0
0
0
0
436,056
0
0
00436,05600000417,704413,857408,758404,116328,314324,914273,012269,581267,089201,203199,223196,972195,573194,226144,975144,044141,733145,428374,278373,864373,352372,699371,893371,091370,236368,190366,366364,471349,236346,229331,224329,727328,116326,492320,024310,600309,343307,497299,244290,159256,563256,267255,418000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
5,858
8,330
51,109
57,374
65,268
169,119
172,387
175,177
177,915
180,580
182,037
183,622
185,161
187,673
188,791
189,584
207,090
208,758
205,629
206,122
206,614
234,849
230,548
230,774
231,094
236,158
255,238
255,416
256,258
258,312
290,160
299,231
307,511
311,094
310,606
319,997
326,530
330,167
329,740
331,241
346,233
351,531
364,456
366,348
368,187
372,831
371,092
371,898
372,701
375,404
373,863
374,278
145,428
142,145
144,044
144,975
194,226
196,906
196,972
199,248
203,876
270,400
273,896
277,986
331,002
59,323
404,116
408,758
413,857
417,704
421,386
424,392
427,042
429,646
431,956
436,056
455,739
457,099
457,099455,739436,056431,956429,646427,042424,392421,386417,704413,857408,758404,11659,323331,002277,986273,896270,400203,876199,248196,972196,906194,226144,975144,044142,145145,428374,278373,863375,404372,701371,898371,092372,831368,187366,348364,456351,531346,233331,241329,740330,167326,530319,997310,606311,094307,511299,231290,160258,312256,258255,416255,238236,158231,094230,774230,548234,849206,614206,122205,629208,758207,090189,584188,791187,673185,161183,622182,037180,580177,915175,177172,387169,11965,26857,37451,1098,3305,858



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue57,306
Cost of Revenue-6,911
Gross Profit50,39550,395
 
Operating Income (+$)
Gross Profit50,395
Operating Expense-60,861
Operating Income-10,466-10,466
 
Operating Expense (+$)
Research Development48,875
Selling General Administrative18,897
Selling And Marketing Expenses6,911
Operating Expense60,86174,683
 
Net Interest Income (+$)
Interest Income1,455
Interest Expense-2,654
Other Finance Cost-1,378
Net Interest Income-2,577
 
Pretax Income (+$)
Operating Income-10,466
Net Interest Income-2,577
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-8,135-12,797
EBIT - interestExpense = -13,120
-8,135
-5,470
Interest Expense2,654
Earnings Before Interest and Taxes (EBIT)-10,466-5,481
Earnings Before Interest and Taxes (EBITDA)-3,555
 
After tax Income (+$)
Income Before Tax-8,135
Tax Provision-27
Net Income From Continuing Ops-26,225-8,162
Net Income-8,124
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses67,772
Total Other Income/Expenses Net2,3312,577
 

Technical Analysis of Molecular Templates Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Molecular Templates Inc. The general trend of Molecular Templates Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Molecular Templates Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Molecular Templates Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1.68 < 2.78 < 3.26.

The bearish price targets are: .

Tweet this
Molecular Templates Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Molecular Templates Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Molecular Templates Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Molecular Templates Inc. The current macd is -0.27420668.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Molecular Templates Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Molecular Templates Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Molecular Templates Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Molecular Templates Inc Daily Moving Average Convergence/Divergence (MACD) ChartMolecular Templates Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Molecular Templates Inc. The current adx is 32.09.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Molecular Templates Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Molecular Templates Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Molecular Templates Inc. The current sar is 1.82289096.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Molecular Templates Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Molecular Templates Inc. The current rsi is 35.08. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Molecular Templates Inc Daily Relative Strength Index (RSI) ChartMolecular Templates Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Molecular Templates Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Molecular Templates Inc price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Molecular Templates Inc Daily Stochastic Oscillator ChartMolecular Templates Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Molecular Templates Inc. The current cci is -68.2536532.

Molecular Templates Inc Daily Commodity Channel Index (CCI) ChartMolecular Templates Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Molecular Templates Inc. The current cmo is -24.89734611.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Molecular Templates Inc Daily Chande Momentum Oscillator (CMO) ChartMolecular Templates Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Molecular Templates Inc. The current willr is -68.75.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Molecular Templates Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Molecular Templates Inc Daily Williams %R ChartMolecular Templates Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Molecular Templates Inc.

Molecular Templates Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Molecular Templates Inc. The current atr is 0.21609686.

Molecular Templates Inc Daily Average True Range (ATR) ChartMolecular Templates Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Molecular Templates Inc. The current obv is 56,161.

Molecular Templates Inc Daily On-Balance Volume (OBV) ChartMolecular Templates Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Molecular Templates Inc. The current mfi is 12.47.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Molecular Templates Inc Daily Money Flow Index (MFI) ChartMolecular Templates Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Molecular Templates Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-22MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-12ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-15MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside

6.3. Candlestick Patterns

Molecular Templates Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Molecular Templates Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.079
Ma 20Greater thanMa 501.777
Ma 50Greater thanMa 1002.613
Ma 100Greater thanMa 2003.220
OpenGreater thanClose1.640
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Molecular Templates Inc with someone you think should read this too:
  • Are you bullish or bearish on Molecular Templates Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Molecular Templates Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Molecular Templates Inc

I send you an email if I find something interesting about Molecular Templates Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Molecular Templates Inc.

Receive notifications about Molecular Templates Inc in your mailbox!